Global PCR-based Mycoplasma Testing Service Market Strategic Research Report

Scope of the Report

The global PCR-based Mycoplasma Testing Service market size is predicted to grow from US$ 657 million in 2025 to US$ 904 million in 2032; it is expected to grow at a CAGR of 4.5% from 2026 to 2032.

PCR-based Mycoplasma Testing Service refers to outsourced laboratory testing services that use PCR, qPCR, or RT-PCR technologies to detect mycoplasma contamination in cell cultures, biologics, vaccines, viral vectors, cell therapy products, raw materials, and research samples. The service provides rapid, sensitive, and specific detection by amplifying mycoplasma DNA or RNA targets. Compared with traditional culture-based methods, PCR-based testing offers shorter turnaround time, higher sensitivity, and better suitability for biopharmaceutical quality control, cell bank release testing, GMP production monitoring, and contamination investigation. The industrial chain of PCR-based Mycoplasma Testing Service includes upstream PCR reagents, primers, probes, nucleic acid extraction kits, enzymes, controls, sample tubes, PCR instruments, qPCR systems, laboratory consumables, cleanroom facilities, and quality management systems. The midstream includes sample receipt, nucleic acid extraction, PCR amplification, assay validation, contamination control, result interpretation, report generation, data review, and regulatory documentation. Downstream applications include biopharmaceutical companies, vaccine manufacturers, cell and gene therapy developers, contract manufacturing organizations, cell banks, research institutes, diagnostic laboratories, and academic laboratories. Related services include method validation, GMP testing, rapid release testing, deviation investigation, contamination source analysis, and technical consulting.

Global key PCR-based Mycoplasma Testing Service players cover Charles River Laboratories International, Thermo Fisher Scientific, SGS, Bionique Testing Laboratories, WuXi AppTec, etc.

This report presents a comprehensive overview of the global PCR-based Mycoplasma Testing Service market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Product Release Testing
• Contamination Investigation Testing
• Regulatory Compliance Testing
• Others

Segment by Sample Type

• Cell Bank Testing
• Cell Culture Testing
• Others

Segment by Application

• Biopharmaceutical Companies
• Contract Research/Manufacturing Organizations (CROs/CMOs)
• Universities and Research Institutions
• Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global PCR-based Mycoplasma Testing Service market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Biopharmaceutical Companies, Contract Research/Manufacturing Organizations (CROs/CMOs), Universities and Research Institutions evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact